![How South Korea Became a Leading Destination for Clinical Trials](https://www.precisionformedicine.com/hs-fs/hubfs/How%20south%20Korea%20Became%20a%20Leading%20Destination%20for%20Clinical%20Trials.jpg?width=396&height=224&name=How%20south%20Korea%20Became%20a%20Leading%20Destination%20for%20Clinical%20Trials.jpg)
![patient-recruitement-2](https://www.precisionformedicine.com/hs-fs/hubfs/PfM%20Website/PfM%20-%20Services%20-%20Specialty%20Labs%20Services/Patient%20Recruitement/patient-recruitement-2.jpg?width=1440&height=672&name=patient-recruitement-2.jpg)
![patient-recruitement-mobile-2](https://www.precisionformedicine.com/hs-fs/hubfs/PfM%20Website/PfM%20-%20Services%20-%20Specialty%20Labs%20Services/Patient%20Recruitement/patient-recruitement-mobile-2.jpg?width=850&height=1440&name=patient-recruitement-mobile-2.jpg)
Patient Recruitment Strategies
Finding the right patients for your trial can be challenging, especially when affected populations are small, such as for rare disease trials.
Contact Us
Precision’s holistic patient recruitment approach leverages our global reach, extensive network of disease researchers, and patient advocacy groups to assemble a strategy to match the patient to your clinical trial based on your study’s criteria. For targeted therapeutics, we use biomarker-driven screening to find the patients expected to respond to your therapeutic, moving quickly and with confidence in data quality thanks to our in-house specialty lab services.
Smart patient recruitment strategies
Our network spans the globe, just like your patients do
![patient_rec_img patient_rec_img](https://www.precisionformedicine.com/hs-fs/hubfs/patient_rec_img.png?width=800&height=540&name=patient_rec_img.png)
Building relationships with communities and specialists
Patient advocacy group relationships and social media outreach help reach into affected communities.
Meanwhile, our established relationships with key opinion leaders and clinical research sites around the globe secure access to a wide range of patient populations.
Case Study: Enrolling a global natural history study: How to find 200 rare patients
A sponsor selected Precision to manage a global natural history study in a rare, X-linked kidney disorder. The study had been recommended by the FDA because there was extremely limited published data on this rare disease—the goal was to characterize renal function and decline in patients with the disease prior to initiating a phase 2/3 clinical study. The study, to be conducted in the United States, Canada, Australia and in Europe, would follow 200+ patients for approximately 2 years.
Enrollment was by far the greatest study challenge, combining a low disease prevalence and a primary target population—young males—with life commitments such as school and work that left little time for participation in a trial that offered no therapeutic benefit for participants and would require traveling to a clinic every 3 to 6 months.
-
At so many levels, the Precision for Medicine team has been fantastic. I am very grateful for how responsive and how collaborative the whole team is. Very grateful for their help.
— Director, Midsize Biotech -
I recognize that relations between Sponsors and CRO vendors can be strained and difficult, often a blaming game; this has never been my experience with this group as it truly felt like a partnership.
— Director, Small Biotech -
Our partnership with Precision is a true textbook definition of a great collaboration between a sponsor and a CRO.
— Senior Director, Midsize Biotech -
Precision is part of our team. They put in long days and hard work to help our study to move forward. We are so appreciative of how fast they worked.
— Senior Manager, Clinical Trials, Midsize Biotech
Read the latest insights on Precision’s blog
Discover expert analysis and broaden your understanding through Precision’s Insights on current research, case studies, and trends.
![How South Korea Became a Leading Destination for Clinical Trials](https://www.precisionformedicine.com/hs-fs/hubfs/How%20south%20Korea%20Became%20a%20Leading%20Destination%20for%20Clinical%20Trials.jpg?width=396&height=224&name=How%20south%20Korea%20Became%20a%20Leading%20Destination%20for%20Clinical%20Trials.jpg)
How South Korea Became a Leading Destination for Clinical Trials
![Immunohistochemistry in Precision Medicine: From Biomarker to Clinical Trial Assay](https://www.precisionformedicine.com/hs-fs/hubfs/Colon%20cancer%20microscopic%20photography%2c%20magnification.jpg?width=396&height=224&name=Colon%20cancer%20microscopic%20photography%2c%20magnification.jpg)
Translational Research - Biomarkers - Assays
Immunohistochemistry in Precision Medicine: From Biomarker to Clinical Trial Assay
|
![Clinical Trial Trends: Multiple Myeloma](https://www.precisionformedicine.com/hs-fs/hubfs/Clinical%20Trial%20Trends%20-%20Miultiple%20Myeloma.jpg?width=396&height=224&name=Clinical%20Trial%20Trends%20-%20Miultiple%20Myeloma.jpg)
![iStock-1420928401](https://www.precisionformedicine.com/hs-fs/hubfs/iStock-1420928401.jpg?width=1440&height=460&name=iStock-1420928401.jpg)
Tell us about your project requirements
Robust patient recruitment is just one reason sponsors choose to work with us. Tell us about your project and we’ll present a plan that will give you dozens more reasons to choose Precision.
Proceed with Precision